Protein recognition via oligonucleotide-linked small molecules: Utilisation of the hemin-binding aptamer

Supramolecular Chemistry

Volumn 21, Issue 3-4, 2009, Pages 316-323

  Harris, D Calvin ^a   Chu, Xiaozhu ^a   Jayawickramarajah, Janarthanan ^a  

^a Tulane University   (United States)

Author keywords

Aptamers; DNA self assembly; DNAzyme; Protein recognition; Supramolecular chemistry

Indexed keywords

EID: 70449727984     PISSN: 10610278     EISSN: 10290478     Source Type: Journal    
DOI: 10.1080/10610270802549717     Document Type: Article

References (43)

1. von Hippel, P.H. Annu. Rev. Biophys. Biomol. Struct. 2007, 36, 79-105.
2. Blackburn, G.M.; Gait, M.J.; Loakes, D.; Williams, D.M. Nucleic Acids in Chemistry and Biology; RSC Publishing: Cambridge, UK, 2006.
3. Ellington, A.D.; Szostak, J.W. Nature 1990, 346, 818-822.
4. Tuerk, C.; Gold, L. Science 1990, 249, 505-510.
5. Bock, L.C.; Griffin, L.C.; Latham, J.A.; Vermaas, E.H.; Toole, J.J. Nature 1992, 355, 564-566.
6. Famulok, M.; Hartig, J.S.; Mayer, G. Chem. Rev. 2007, 107, 3715-3743.
7. Brenner, S.; Lerner, R.A. Proc. Natl Acad. Sci. USA 1992, 89, 5381-5383.
8. Needels, M.C.; Jones, D.G.; Tate, E.H.; Heinkel, G.L.; Kochersperger, L.M.; Dower, W.J.; Barrett, R.W.; Gallop, M.A. Proc. Natl Acad. Sci. USA 1993, 90, 10700-10704.
9. Halpin, D.R.; Harbury, P.B. PLoS Biol. 2004, 2, 1015-1021
10. ODN moiety is used to direct specific sequences of DNA-linked materials to appropriate columns (containing their complementary sequence) for subsequent selective synthetic transformations. Such an approach enables the conversion of genetic information into chemical functionality that can be used for subsequent target protein-binding
11. Halpin, D.R.; Harbury, P.B. PLoS Biol. 2004, 2, 1022-1030.
12. Doyon, J.B.; Snyder, T.M.; Liu, D.R. J. Am. Chem. Soc. 2003, 125, 12372-12373.
13. Saghatelian, A.; Guckian, K.M.; Thayer, D.A.; Ghadiri, M.R. J. Am. Chem. Soc. 2003, 125, 344-345.
14. Gianneschi, N.C.; Ghadiri, M.R. Angew. Chem., Int. Ed. 2007, 46, 3955-3958.
15. Sprinz, K.I.; Tagore, D.M.; Hamilton, A.D. Bioorg. Med. Chem. Lett. 2005, 15, 3908-3911.
16. Melkko, S.; Scheuermann, J.; Dumelin, C.E.; Neri, D. Nat. Biotechnol. 2004, 22, 568-574.
17. Tagore, D.M.; Sprinz, K.I.; Hamilton, A.D. Supramol. Chem. 2007, 19, 129-136.
18. Melkko, S.; Dumelin, C.E.; Scheuermann, J.; Neri, D. Drug Discov. Today 2007, 12, 465-471.
19. Melkko, S.; Dumelin, C.E.; Scheuermann, J.; Neri, D. Chem. Biol. 2006, 13, 225-231.
20. Scheuermann, J.; Dumelin, C.E.; Melkko, S.; Zhang, Y.; Mannocci, L.; Jaggi, M.; Sobek, J.; Neri, D. Bioconjugate Chem. 2008, 19, 778-785.
21. Melkko, S.; Zhang, Y.; Dumelin, C.E.; Scheuermann, J.; Neri, D. Angew. Chem., Int. Ed. 2007, 46, 4671-4674.
22. Tagore, D.M.; Sprinz, K.I.; Fletcher, S.; Jayawickramarajah, J.; Hamilton, A.D. Angew. Chem., Int. Ed. 2007, 46, 223-225.
23. Nam, J.-M.; Park, S.-J.; Mirkin, C.D. J. Am. Chem. Soc. 2002, 124, 3820-3821.
24. Niemeyer, C.M.; Adler, M.; Gao, S.; Chi, L. Angew. Chem., Int. Ed. 2000, 39, 3055-3059.
25. Bagalkot, V.; Zhang, L.; Levy-Nissenbaum, E.; Jon, S.; Kantoff, P.W.; Langer, R.; Farokhzad, O.C. Nano Lett. 2007, 7, 3065-3070.
26. So, H.-M.; Won, K.; Kim, Y.H.; Kim, B.-K.; Ryu, B.H.; Na, P.S.; Kim, H.; Lee, J.-O. J. Am. Chem. Soc. 2005, 127, 11906-11907.
27. Jayasena, S.D. Clin. Chem. 1999, 45, 1628-1650.
28. Shlyahovsky, B.; Li, D.; Katz, E.; Willner, I. Biosens. Bioelectron. 2007, 22, 2570-2576. The majority of chemical alterations undertaken on aptamers have focused on modifying the core oligonucleotide sequence to improve their drug-like activity (i.e. enhancing nuclease resistance and/or primary target affinity)
29. Wilson, C.; Keefe, A.D. Curr. Opin. Chem. Biol. 2006, 10, 607-614.
30. Bugaut, A.; Toulme, J.-J.; Rayner, B. Org. Biomol. Chem. 2006, 4, 4082-4088
31. Weber, P.C.; Ohlendorf, D.H.; Wendoloski, J.J.; Salemme, F.R. Science 1989, 243, 85-88.
32. Ostatna, V.; Vaisocherova, H.; Homola, J.; Hianik, T. Anal. Bioanal. Chem. 2008, 391, 1861-1869
33. Baldrich, E.; Restrepo, A.; O'Sullivan, C.K. Anal. Chem. 2004, 76, 7053-7063.
34. Collet, J.R.; Cho, E.J.; Lee, J.F.; Levy, M.; Hood, A.J.; Wan, C.; Ellington, A.D. Anal. Biochem. 2005, 338, 113-123.
35. Travascio, P.; Li, P.; Sen, D. Chem. Biol. 1998, 5, 505-517.
36. Travascio, P.; Bennet, A.; Sen, D. Chem. Biol. 1999, 6, 779-787.
37. Travascio, P.; Sen, D.; Bennet, A.J. Can. J. Chem. 2006, 84, 613-619.
38. It should be noted that Willner and co-workers have elegantly demonstrated that the allosteric nature of the hemin-binding aptamer (when tethered to other nucleic acid sequences or proteins) can lead to bifunctional molecules capable of detecting various agents of import (including DNA, AMP, lysozyme and glucose).
39. Pavlov, V.; Xiao, Y.; Gill, R.; Dishon, A.; Kotler, M.; Willner, I. Anal. Chem. 2004, 76, 2152-2156.
40. Li, D.; Shlyahovsky, B.; Elbaz, J.; Willner, I. J.Am. Chem. Soc. 2007, 129, 5804-5805
41. In addition, Kolpashchikov has recently shown that an ODN containing the hemin-binding aptamer can be split into binary components that selfassemble in the presence of a specific DNA sequence and hence can be used as a probe for detecting single nucleotide polymorphism
42. Kolpashchikov, D.M. J. Am. Chem. Soc. 2008, 130, 2934-2935
43. However, to the best of our knowledge, there has been no exploration of using the hemin-binding aptamer linked to a synthetic fragment for targeted protein-binding and detection.